Categories: AnalystsCannabis

Why aren’t large funds playing cannabis stocks?

Myles Zyblock on BNN.
In a sign that marijuana has truly hit the big time, Smiths Falls, Ontario’s Canopy Growth Corp. (TSE:WEED) turned a lot of heads yesterday by announcing a partnership with beer and liquor giant Constellation Brands. The move gives the US-based Constellation a ten per cent stake in Canopy and effectively signals to other producers in the burgeoning cannabis trade that the corporate world is finally warming up to the pot business.

Then why are fund managers still so cagey about marijuana?

It’s not about optics, for sure, the big players in Canada’s pot scene are run by folks who are pretty far from being hippy potheads in dreadlocks. By now, they’re all C-Suite execs with plenty of corporate experience: Bruce Linton is head of Canopy, Vic Neufeld is at Aphria, Barry Fishman is at ABcann —the list goes on.

And, surely, it’s not still a moral squeamishness connected to the pot business that’s holding back the money managers, since they know as well as we do that no one cares anymore who smokes weed or, for that matter, whose investment portfolio might have a funky green haze about it.

In the end, of course, it’s the big pile of known unknowns that’s keeping the big investment companies at arm’s length. And the pending issues are significant: people want to know when the drug will become legalized, how each province is going to regulate the sale of cannabis and, perhaps the biggest question mark, how big will the industry get?

But we won’t have to wait much longer for the institutional money to come knocking, says Myles Zyblock, Chief Investment Strategist at Dynamic Funds, since as soon as the industry in Canada gets up and stabilized, the fund managers will be ready to dive in.

“It’s not just the legality, there’s still a lot of uncertainty around the industry,” says Zyblock, in conversation with BNN. “It’s still hard to gauge. When you’re trying to put capital to work, you have to be comfortable with what you know and what you don’t know.”

Zyblock says the caginess is nothing new but that it stems from past experience. “Historically, when you have these new industries that appear out of nowhere —  take the dot-com industry, for example, it was like a gold rush, with blue-sky stories feeding people’s enthusiasm,” says Zyblock. “Ultimately, reality kicks in where regulations come into play, financial oversight. Then you have a reset of expectations, a cooling off period, and then you have something real.”

Zyblock says that at the moment, the industry is too story-driven, with every new news item causing investors to either pile on or pull out, making for a much too rocky road for most major firms. That doesn’t mean they’re not paying attention, however.

“We have teams of portfolio managers and analysts poring over the industry. We have to be prepared,” says Zyblock. “I think this industry will be around in ten years, it’s not going away like tobacco did. It’s a real industry and Constellation’s participation is validation of that.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago